|
Volumn 224, Issue 6, 2012, Pages 395-397
|
Kaposiform hemangioendothelioma with kasabach-merritt phenomenon: From vincristine to sirolimus
a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOPHOSPHAMIDE;
PREDNISOLONE;
PROPRANOLOL;
RAPAMYCIN;
VINCRISTINE;
ABDOMEN;
ABDOMINAL GIRTH;
ANEMIA;
ARTICLE;
BLOOD CLOTTING;
CASE REPORT;
CHRONIC DISEASE;
DISEASE ASSOCIATION;
DISSEMINATED INTRAVASCULAR CLOTTING;
DRUG DOSE REDUCTION;
ERYTHROCYTE TRANSFUSION;
FEMALE;
HEMANGIOENDOTHELIOMA;
HEMATOMA;
HUMAN;
HUMAN TISSUE;
HYPERVASCULAR TUMOR;
KAPOSIFORM HEMANGIOENDOTHELIOMA;
KASABACH MERRITT SYNDROME;
LAPAROTOMY;
LIVER DISEASE;
NEWBORN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PALLOR;
PETECHIA;
RETROPERITONEAL TUMOR;
SINGLE DRUG DOSE;
SKIN DISCOLORATION;
SUBSCAPULAR HEMATOMA;
THROMBOCYTE COUNT;
THROMBOCYTE TRANSFUSION;
THROMBOCYTOPENIA;
VASCULAR TUMOR;
ANTI-INFLAMMATORY AGENTS;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DISSEMINATED INTRAVASCULAR COAGULATION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG SUBSTITUTION;
FEMALE;
FOLLOW-UP STUDIES;
HEMANGIOENDOTHELIOMA;
HUMANS;
INFANT;
INFANT, NEWBORN;
KASABACH-MERRITT SYNDROME;
PLATELET COUNT;
PREDNISOLONE;
RETROPERITONEAL NEOPLASMS;
SARCOMA, KAPOSI;
SIROLIMUS;
SKIN NEOPLASMS;
TOR SERINE-THREONINE KINASES;
VINCRISTINE;
|
EID: 84869095212
PISSN: 03008630
EISSN: 14393824
Source Type: Journal
DOI: 10.1055/s-0032-1323823 Document Type: Article |
Times cited : (34)
|
References (0)
|